Future Science Group
Browse
Download file
Download file
Download file
Download file
1/1
4 files

Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapy. Supplementary figures

figure
posted on 2023-03-07, 08:41 authored by Xichen Zheng, Jiajie Kuai, Guanghui Shen

Supplementary figures 1-4

History